Medtronic exits “unprofitable” ventilator market
Current North America and Europe market leader drops ventilator product lines, pivots to form Acute Care and Monitoring business.
21 February 2024
21 February 2024
Current North America and Europe market leader drops ventilator product lines, pivots to form Acute Care and Monitoring business.
The funding is being used to accelerate the company’s FASTR Trial, which is examining the company’s system for the treatment of acute decompensated heart failure.
The device, Endoscopic image diagnosis support software - gastroAI-model G, can differentiate gastric lesions during endoscopy.
The LEARNS study, which is a two-part observational basket study, will enrol up to 70 participants with Parkinson’s disease.
The trial will evaluate the safety and efficacy of the latest version of Hēlo, which now has a new accessory device.
Serranator is intended for dilatation of lesions in various arteries, including the iliac, femoral, iliofemoral.
The microrobot, under development at the multi-scale Robotics Lab in Zurich, helps navigate catheters faster and more accurately in brain surgery.
The patient monitoring device was designed as an alternative to in-clinic tests designed to track a patient’s biopotential signals from brain activity to eye movement.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.